Brian F. Volkman, PhD
Director, Program in Chemical Biology; Professor, Biochemistry
Locations
- Biochemistry
TBRC C3815
Contact Information
Education
BS, Butler University, 1989
Biography
Dr. Volkman obtained his Bachelor of Science degree in Chemistry and Physics from Butler University in 1989 and his Doctorate degree from The University of California at Berkeley. The latter was awarded in 1994 for structural studies on proteins involved in bacterial gene regulation using NMR spectroscopy. Dr. Volkman's postdoctoral training was in the Department of Biochemistry at the University of Wisconsin-Madison. In 2000, Dr. Volkman started at the Medical College of Wisconsin where he is Professor in the Biochemistry Department. Dr. Volkman's work focuses on the structural biology of immunological signaling molecules and the use of NMR spectroscopy in structural proteomics.
Research Experience
- Amino Acid Sequence
- Binding Sites
- Chemokine CCL21
- Chemokine CXCL12
- Chemokines
- Chemokines, C
- Chemokines, CXC
- Chemotaxis
- Computational Biology
- Crystallography, X-Ray
- Dimerization
- Drug Design
Research Interests
Our goal is to invent new ways to treat cancer and other ailments by examining the three-dimensional architecture of proteins involved in disease and synthesizing new drug candidate molecules. This research links the expertise of chemists, structural biologists, and clinician-scientists who collaborate in the design and testing of potential therapies. Graduate students in my group have invented and patented new compounds that show promise as treatments for cancer and psoriasis. Your donation helps us accelerate the drug development process by paying for preclinical studies that most research grants simply won’t support - bridging the gap between our basic science discoveries and clinical trials.
We use NMR spectroscopy and many other techniques to (1) understand the transmission of biological signals in terms of molecular structure, recognition and dynamics and (2) exploit this knowledge for the design and discovery of new molecules with practical utility as research tools, bioactive nanomaterials, or new drugs.
Dynamics and folding. Protein function is exquisitely dependent on compactly folded structures that combine energetic stability with intrinsic flexibility. Our work has revealed surprising new examples of conformational variability and altered the established paradigm for protein folding to include the new category of ‘metamorphic’ proteins. We are now trying to define the thermodynamic and evolutionary origins of metamorphic folding using the divergence of human lymphotactin from the rest of the chemokine family as a prototypical example. Other projects analyze novel modes of conformational switching that control cell polarity and enzyme activity.
Molecular recognition. Biological signals are often controlled by promoting or disrupting the interaction between two proteins. Many chemokines have been directly implicated in human diseases. Compounds that block chemokine signaling might function as inhibitors of inflammation, cancer progression, viral infection or autoimmune disease. We recently used NMR to solve the structure of the first chemokine-receptor complex, and subsequently used the details of this interface to search for small molecule ligands that bind the chemokine and block its activity. A hybrid in silico/NMR approach to inhibitor screening is now being used to target multiple chemokines with the ultimate goal of drug discovery to treat metastatic cancer and psoriasis.
Lab Photo

Back Row L. to R.: Chris Veldkamp, Francis Peterson, Rob Tyler, Anthony Getschman (hands), Austin Jiang,
Alex Chadwick, Davin Jensen, Dustin Whitney and Josh Weiner
Middle Row L. to R.: Chad Koplinski, Amanda Nevins
First Row L. to R.: Dr. Brian Volkman, Echo the dog, Jamie Wieting, Becky Holme
Publications
-
(Rosenkilde MM, Volkman BF, Peterson FC, Veldkamp CT, Hjortø GM.) Basic Clin Pharmacol Toxicol. 2026 Sep;139(3):e70289 PMID: 42622342 PMCID: PMC13492094 SCOPUS ID: 2-s2.0-105047862145 08/20/2026
-
(Weiss MS, Mueller U, Velankar S, Hoch JC, Pustovalova Y, Schwalbe H, Sreeramulu S, Arthanari H, Volkman BF.) Structure. 6 August 2026;34(8):1099-1102 SCOPUS ID: 2-s2.0-105046427315 08/06/2026
-
Biosafety assessment of engineered CCL20 locked dimers in vivo.
(Drouillard D, Poimenidou M, Davies M, McAllister D, Clarke WR, Hwang ST, Peterson FC, Volkman BF, Dwinell MB.) Cell Biol Toxicol. 2025 Dec 19;42(1):14 PMID: 41419693 PMCID: PMC12799736 SCOPUS ID: 2-s2.0-105027326723 12/20/2025
-
Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies.
(Perez Almeria CV, Otun O, Schlimgen R, Lamme TD, Di Niro L, Crudden C, Bebelman JP, Youssef N, Musli L, Jenjak S, Bobkov V, Drube J, Hoffmann C, Volkman BF, Granier S, Bechara C, Siderius M, Heukers R, Schafer CT, Smit MJ.) Nat Commun. 2025 Dec 02;16(1):10828 PMID: 41330916 PMCID: PMC12673113 SCOPUS ID: 2-s2.0-105023578189 12/03/2025
-
Progress toward new function and design of extracellular G protein-coupled receptor nanobodies.
(Schlimgen RR, Volkman BF.) Mol Pharmacol. 2025 Aug;107(8):100054 PMID: 40694881 PMCID: PMC13095440 SCOPUS ID: 2-s2.0-105010895774 07/23/2025
-
Encoding and decoding selectivity and promiscuity in the human chemokine-GPCR interaction network.
(Kleist AB, Szpakowska M, Talbot LJ, Slodkowicz G, Malinverni D, Thomas MA, Crawford KS, McGrail DJ, Dishman AF, Wedemeyer MJ, Sluter M, Yi SS, Sahni N, Peterson FC, Chevigné A, Volkman BF, Babu MM.) Cell. 2025 Jun 26;188(13):3603-3622.e27 PMID: 40273912 PMCID: PMC12435897 SCOPUS ID: 2-s2.0-105003480354 04/25/2025
-
(Pontejo SM, Martinez S, Zhao A, Barnes K, de Anda J, Alimohamadi H, Lee EY, Dishman AF, Volkman BF, Wong GCL, Garboczi DN, Ballesteros A, Murphy PM.) Sci Adv. 2025 Jun 06;11(23):eads2675 PMID: 40479071 PMCID: PMC12143392 SCOPUS ID: 2-s2.0-105007978082 06/06/2025
-
(Luís R, Volkman BF, Szpakowska M, Chevigné A.) J Leukoc Biol. 2025 Apr 23;117(4) PMID: 39903605 PMCID: PMC12017343 SCOPUS ID: 2-s2.0-105003675712 02/04/2025
-
The multifaceted role of XCL1 in health and disease.
(Syed M, Dishman AF, Volkman BF, Walker TL.) Protein Sci. 2025 Feb;34(2):e70032 PMID: 39840812 PMCID: PMC11751857 SCOPUS ID: 2-s2.0-85215400606 01/22/2025
-
(Zhang BB, Harrison K, Zhong Y, Maxwell JWC, Ford DJ, Calvey LP, So SS, Peterson FC, Volkman BF, Stone MJ, Bhusal RP, Kulkarni SS, Payne RJ.) J Am Chem Soc. 2024 Dec 18;146(50):34253-34259 PMID: 39629944 SCOPUS ID: 2-s2.0-85211025577 12/04/2024
-
(Zhang BB, Harrison K, Zhong Y, Maxwell JWC, Ford DJ, Calvey LP, So SS, Peterson FC, Volkman BF, Stone MJ, Bhusal RP, Kulkarni SS, Payne RJ.) Journal of the American Chemical Society. 18 December 2024;146(50):34253-34259 SCOPUS ID: 2-s2.0-85211025577 12/18/2024